SEARCH   
MEMBER LOGIN    
Forgot Password?

ADHD Medication Manufacturing: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

ADHD Medication Manufacturing Market Research Report | NAICS OD4146 | Aug 2016

In good health: Wider recognition and increasing health reforms will support the industry

IBISWorld’s ADHD Medication Manufacturing market research report provides the latest industry statistics and industry trends, allowing you to identify the products and customers driving revenue growth and profitability. The industry report identifies the leading companies and offers strategic industry analysis of the key factors influencing the market.

Report Snapshot
Market Share of Companies
Industry Statistics & Market Size
Revenue
$13bn
Annual Growth 11-16
5.2%
Annual Growth 16-21
Add to Cart
Profit
Add to Cart
Employment
13,216
Businesses
233
Industry Analysis & Industry Trends

The use of medication for the treatment of attention deficit disorders, such as ADHD, is growing. The recent recognition of ADHD as a condition that can also afflict adults has provided a boon to the industry, and healthcare reform has enabled more children to access behavioral health services, resulting in more patients being able to have their ADHD identified and treated. In the five years to 2021, industry revenue will continue to grow as the trends from the previous five years bolster utilization rates. However, many brand-name drugs are set to lose their patent exclusivity, which will incite more generic drug manufacturers to inundate the market with low-cost drugs, intensifying price-based competition... purchase to read more

Industry Report - Industry SWOT Analysis Chapter

The ADHD Medication Manufacturing industry is currently in the growth life cycle stage. During the 10 years to 2021, industry value added (IVA), which measures an industry's contribution to the overall economy, is expected to grow at an annualized rate of 6.2%. Comparatively, US GDP is anticipated to grow at an annualized 2.1% over the same period. According to data from Healthline, the number of individuals treated for ADHD in the United States has skyrocketed 42.0% over the eight years to 2014 (latest data available), which has provided a boon to the industry. Further benefiting the industry, in 2013, the American Psychiatric Association established guidelines for healthcare providers to diagnose adults with ADHD.

.. purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the ADHD Medication Manufacturing Industry?

This industry manufactures medications that treat people with attention deficits, such as attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD).

Industry Products
Amphetamine and dextroamphetamine medicationsMethylphenidate and dexmethylphenidate medicationsLisdexamfetamine medications
 
Industry Activities
Manufacturing ADD drugs Manufacturing ADHD drugs Conducting clinical trials Researching and developing new drugs


View Sample
Quote
Select Clients